34.42 0.00 (0.00%)
After hours: 4:54PM EDT
|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||34.41 - 35.58|
|52 Week Range||29.56 - 46.81|
|PE Ratio (TTM)||47.81|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Since Repligen Corporation (NASDAQ:RGEN) released its earnings in December 2017, analyst consensus outlook seem bearish, as a -50.53% fall in profits is expected in the upcoming year against the pastRead More...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding RGEN totaled $155 million.
The Waltham, Massachusetts-based company said it had profit of 27 cents per share. Earnings, adjusted for one-time gains and costs, came to 20 cents per share. The results exceeded Wall Street expectations. ...
Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.
Categories: Yahoo FinanceGet free summary analysis Repligen Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Repligen Corp. – Novavax, Inc., Neurocrine Biosciences, Inc., Caladrius Biosciences, Inc., Pfizer Inc., Sangamo Therapeutics, Inc. and Charles River Laboratories International, Inc. (NVAX-US, NBIX-US, CLBS-US, PFE-US, SGMO-US and CRL-US) ... Read more (Read more...)
Repligen Corporation (NASDAQ:RGEN) generated a below-average return on equity of 5.70% in the past 12 months, while its industry returned 16.06%. Though RGEN’s recent performance is underwhelming, it is usefulRead More...
This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on November 7. Index (PMI) data, output in the Healthcare sector is rising.
The Waltham, Massachusetts-based company said it had profit of 11 cents per share. Earnings, adjusted for one-time gains and costs, were 15 cents per share. The results surpassed Wall Street expectations. ...
Repligen Corporation (RGEN) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Repligen Corp. Here are 5 ETFs with the largest exposure to RGEN-US. Comparing the performance and risk of Repligen Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)